IGF2 and pancreatic neuroendocrine tumor: Biochemistry demonstrated suppressed insulin, C-peptide, and GH, with a disproportionately elevated IGF-II level and a raised IGF-II to IGF-I ratio, consistent with non-islet cell tumour hypoglycaemia.